Eribulin mesylate injection
Products billed under this code include Eribulin Mesylate, Halaven.
Payment limit per 0.1 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.Products billed under J9179
From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Eribulin Mesylate | Hikma Pharmaceuticals USA Inc. | 00143-9167-01 | 10 | $639.72 |
| Eribulin Mesylate | Sandoz Inc. | 00781-3391-94 | 10 | $639.72 |
| Eribulin Mesylate | Baxter Healthcare Corporation | 10019-0080-01 | 10 | $639.72 |
| Eribulin Mesylate | XGen Pharmaceuticals DJB, Inc. | 39822-2080-01 | 10 | $639.72 |
| Eribulin Mesylate | Dr. Reddy's Laboratories Inc. | 43598-0125-11 | 10 | $639.72 |
| Eribulin Mesylate | Apotex Corp | 60505-6289-00 | 10 | $639.72 |
| Eribulin Mesylate | BluePoint Laboratories | 68001-0656-41 | 10 | $639.72 |
| Eribulin Mesylate | Glenmark Pharmaceuticals Inc., USA | 68462-0770-20 | 10 | $639.72 |
| Eribulin Mesylate | Northstar RxLLC | 72603-0368-01 | 10 | $639.72 |
| Eribulin Mesylate | Long Grove Pharmaceuticals, LLC | 81298-3890-01 | 10 | $639.72 |
Show all 11 products
| Product | Labeler | NDC | Units / pkg | Limit / pkg |
|---|---|---|---|---|
| Halaven | Eisai Inc. | 62856-0389-01 | 10 | $639.72 |
Every quarter
| Quarter | Payment limit | Change | Billing unit | Description | Source file |
|---|---|---|---|---|---|
| 4Q26 | $63.972 | +$3.993 | 0.1 MG | Eribulin mesylate injection | v1, posted September 17, 2026 |
| 3Q26 | $59.979 | −$16.777 | 0.1 MG | Eribulin mesylate injection | v1, posted September 15, 2026 |
| 2Q26 | $76.756 | +$4.148 | 0.1 MG | Eribulin mesylate injection | v1, posted September 15, 2026 |
| 1Q26 | $72.608 | −$16.736 | 0.1 MG | Eribulin mesylate injection | v1, posted September 15, 2026 |
| 4Q25 | $89.344 | −$15.24 | 0.1 MG | Eribulin mesylate injection | v1, posted September 8, 2026 |
| 3Q25 | $104.584 | −$14.165 | 0.1 MG | Eribulin mesylate injection | v1, posted March 10, 2026 |
| 2Q25 | $118.749 | −$14.568 | 0.1 MG | Eribulin mesylate injection | v1, posted March 10, 2026 |
| 1Q25 | $133.317 | −$2.468 | 0.1 MG | Eribulin mesylate injection | v1, posted December 19, 2025 |
| 4Q24 | $135.785 | −$5.508 | 0.1 MG | Eribulin mesylate injection | v1, posted June 11, 2025 |
| 3Q24 | $141.293 | +$3.502 | 0.1 MG | Eribulin mesylate injection | v1, posted June 11, 2025 |
| 2Q24 | $137.791 | +$1.603 | 0.1 MG | Eribulin mesylate injection | v1, posted March 11, 2025 |
| 1Q24 | $136.188 | +$5.314 | 0.1 MG | Eribulin mesylate injection | v1, posted December 19, 2024 |
| 4Q23 | $130.874 | +$2.097 | 0.1 MG | Eribulin mesylate injection | v1, posted October 10, 2024 |
| 3Q23 | $128.777 | +$1.858 | 0.1 MG | Eribulin mesylate injection | v1, posted June 5, 2024 |
| 2Q23 | $126.919 | +$0.293 | 0.1 MG | Eribulin mesylate injection | v1, posted February 23, 2024 |
| 1Q23 | $126.626 | +$0.946 | 0.1 MG | Eribulin mesylate injection | v1, posted December 6, 2023 |
| 4Q22 | $125.68 | −$3.314 | 0.1 MG | Eribulin mesylate injection | v1, posted June 22, 2023 |
| 3Q22 | $128.994 | −$0.359 | 0.1 MG | Eribulin mesylate injection | v1, posted June 9, 2023 |
| 2Q22 | $129.353 | +$1.917 | 0.1 MG | Eribulin mesylate injection | v1, posted December 14, 2022 |
| 1Q22 | $127.436 | +$3.506 | 0.1 MG | Eribulin mesylate injection | v1, posted June 8, 2022 |
| 4Q21 | $123.93 | +$2.643 | 0.1 MG | Eribulin mesylate injection | v1, posted June 2, 2022 |
| 3Q21 | $121.287 | +$3.38 | 0.1 MG | Eribulin mesylate injection | v1, posted June 2, 2022 |
| 2Q21 | $117.907 | +$0.145 | 0.1 MG | Eribulin mesylate injection | v1, posted March 1, 2022 |
| 1Q21 | $117.762 | – | 0.1 MG | Eribulin mesylate injection | v1, posted December 10, 2021 |
“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.
CMS source files
- 4Q26: 2026-09-17_october-2026-medicare-part-b-payment-limit-files-final.zipposted September 17, 2026
- 4Q26: 2026-09-17_october-2026-ndc-hcpcs-crosswalk-final.zipposted September 17, 2026
- 3Q26: 2026-09-15_july-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 2Q26: 2026-09-15_april-2026-medicare-part-b-payment-limit-files-final-file.zipposted September 15, 2026
- 1Q26: 2026-09-15_january-2026-medicare-part-b-payment-limit-files.zipposted September 15, 2026
- 4Q25: 2026-09-08_october-2025-asp-pricing-final-file.zipposted September 8, 2026
- 3Q25: 2026-03-10_july-2025-asp-pricing-file.zipposted March 10, 2026
- 2Q25: 2026-03-10_april-2025-asp-pricing-file.zipposted March 10, 2026
- 1Q25: 2025-12-19_january-2025-asp-pricing-file-03-11-25-final-file.zipposted December 19, 2025
- 4Q24: 2025-06-11_october-2024-asp-pricing-file.zipposted June 11, 2025
- 3Q24: 2025-06-11_july-2024-asp-pricing-file.zipposted June 11, 2025
- 2Q24: 2025-03-11_april-2024-asp-pricing-file.zipposted March 11, 2025
- 1Q24: 2024-12-19_january-2024-asp-pricing-file.zipposted December 19, 2024
- 4Q23: 2024-10-10_october-2023-asp-pricing-file.zipposted October 10, 2024
- 3Q23: 2024-06-05_july-2023-asp-pricing-file.zipposted June 5, 2024
- 2Q23: 2024-02-23_april-2023-asp-pricing-file.zipposted February 23, 2024
- 1Q23: 2023-12-06_january-2023-asp-pricing-file.zipposted December 6, 2023
- 4Q22: 2023-06-22_october-2022-asp-pricing-file.zipposted June 22, 2023
- 3Q22: 2023-06-09_july-2022-asp-pricing-file.zipposted June 9, 2023
- 2Q22: 2022-12-14_april-2022-asp-pricing-file.zipposted December 14, 2022
- 1Q22: 2022-06-08_january-2022-asp-pricing-file.zipposted June 8, 2022
- 4Q21: 2022-06-02_october-2021-asp-pricing-file.zipposted June 2, 2022
- 3Q21: 2022-06-02_july-2021-asp-pricing-file.zipposted June 2, 2022
- 2Q21: 2022-03-01_april-2021-asp-pricing-file.zipposted March 1, 2022
- 1Q21: 2021-12-10_january-2021-asp-pricing-file.zipposted December 10, 2021